Yange Tian

13PUBLICATIONS
13CO-AUTHORS
Biomechanical engineeringMechanobiologyTraditional Chinese medicine and treatmentsNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 11, 2026
Effective-Component Compatibility of Bufei Yishen Formula III Improves Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Responses Through Blocking PTX3 Activation.

|Jul 01, 2026
Effective-Component Compatibility of Bufei Yishen Formula Alleviates Alveolar Epithelial Barrier Damage in COPD Through Inhibition of p38 MAPK Phosphorylation.

|Mar 23, 2026
Effective Component Compatibility of Bufei Yishen Formula III Alleviates Pulmonary Vascular Inflammation in COPD: Via VEGF165/P38 MAPK Pathway.

Qinghua Song, Lili Cui, Ruilong Lu

|Jul 10, 2025
Effective-Component Compatibility of Bufei Yishen Formula III Protects Lung Air-Blood Barrier by Regulating the Oxidative Stress: via the Nuclear Factor-E2-Related Factor 2 Pathway.

Kexin Xu, Xuejie Shao, Ruilong Lu

|Jan 29, 2025
The Effective Compound Combination of Bufei Yishen Formula III Improves the Mitochondrial Dysfunction via Inhibiting JNK/Sab Pathway in COPD Mice.

Mengwei Song, Mi Han, Haoyu Zhang

|Aug 10, 2024
Impact of different processing methods of Ligustrum lucidum Ait. on kidney-yin deficiency: a study based on pharmacodynamics and metabolomics research.

Shu-Ding Sun, Di Zhao, Xue-Fang Liu

Pageof 3

Frequent Collaborators

4 joint publications

Jiansheng Li

3 joint publications

Jiansheng Li

2 joint publications

Suxiang Feng

2 joint publications

Ya Li